Lopatko Lindman, Karin
Jonsson, Caroline
Weidung, Bodil
Olsson, Jan
Pandey, Janardan P.
Prokopenko, Dmitry
Tanzi, Rudolph E.
Hallmans, Göran
Eriksson, Sture
Elgh, Fredrik
Lövheim, Hugo
Funding for this research was provided by:
the Kempe Foundation
the Swedish Dementia Association
Cure Alzheimer’s Fund
Region Västerbotten
Wallenberg Centre for Molecular Medicine in Umeå
the Swedish Medical Association
the Swedish Alzheimer Fund
Umeå University
Umea University
Article History
Received: 14 February 2022
Accepted: 20 July 2022
First Online: 2 August 2022
Competing interests
: All authors declare no competing interests directly related to this project. R.T reported the following interests, unrelated to the submitted work: Financial Interest only: Amylyx / React Neuro / Cognitive Clarity / DRADS Capital / Verge Genomics / Cognoptix / Genomind / Interaxon/ Neurogenetics. Paid Consultant and Financial Interest: MarvelBiome / AZTherapies / Promis / Cerevance / Chromadex / Jefferson Pharmaceuticals / Annovis Bio/ TrialSight. Paid Consultant only: Takeda / FujiFilm / CAMP4 / Sarepta / Neurona.